Evidence map›Paper›PMID 25174669›Full record

ArticleActa biomaterialia2014

Novel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defects.

Sungwoo Kim, Katherine Bedigrew, Teja Guda, William J Maloney, Sangwon Park, Joseph C Wenke, Yunzhi Peter Yang

Abstract read
In one paragraph

Article in Acta biomaterialia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Regeneration enhanced in critical-sized bone defects using bone-specific extracellular matrix protein.Journal of biomedical materials research. Part B, Applied biomaterials · 2021
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Vascularization in bone tissue engineering constructs.Annals of biomedical engineering · 2015
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sungwoo KimDepartment of Orthopedic Surgery, Stanford University, Stanford, CA, USA.
Katherine BedigrewExtremity Trauma & Regenerative Medicine Task Area, US Army Institute of Surgical Research, San Antonio, TX, USA.
Teja GudaDepartment of Craniomaxillofacial Regenerative Medicine, Dental and Trauma Research Detachment, United States Army Institute of Surgical Research, Fort Sam Houston, TX, USA.
William J MaloneyDepartment of Orthopedic Surgery, Stanford University, Stanford, CA, USA.
Sangwon ParkDepartment of Prosthodontics, Dental Science Research Institute and BK21 Project, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.
Joseph C WenkeExtremity Trauma & Regenerative Medicine Task Area, US Army Institute of Surgical Research, San Antonio, TX, USA.
Yunzhi Peter YangDepartment of Orthopedic Surgery, Stanford University, Stanford, CA, USA; Department of Materials Science and Engineering, Stanford University, Stanford, CA, USA. Electronic address: ypyang@stanford.edu.

Funding

Microengineered Osteons for Bone Tissue EngineeringR01AR057837 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2010 to 2018
$5.1M
Engineering Vascularized Bone Tissues By Microfabrication And ScaffoldingR01DE021468 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2011 to 2014
$1.8M
NIAMS NIH HHS R01 AR057837NIAMS NIH HHS R01AR057837NIDCR NIH HHS R01 DE021468NIDCR NIH HHS R01DE021468
6 · The paper itself

Abstract

The purpose of this study was to develop and characterize a novel photo-cross-linkable chitosan-lactide-fibrinogen (CLF) hydrogel and evaluate the efficacy of bone morphogenetic protein-2 (BMP-2) containing a CLF hydrogel for osteogenesis in vitro and in vivo. We synthesized the CLF hydrogels and characterized their chemical structure, degradation rate, compressive modulus and in vitro BMP-2 release kinetics. We evaluated bioactivities of the BMP-2 containing CLF hydrogels (0, 50, 100 and 500ngml(-1)) in vitro using W-20-17 preosteoblast mouse bone marrow stromal cells and C2C12 mouse myoblast cells. The effect of BMP-2 containing CLF gels (0, 0.5, 1, 2 and 5μg) on bone formation was evaluated using rat critical size segmental bone defects for 4weeks. Fourier transform infrared spectroscopy spectra and scanning electron microscopy images showed chemical and structural changes by the addition of fibrinogen into the chitosan-lactide copolymer. The incorporation of fibrinogen molecules significantly increased the compressive modulus of the hydrogels. The in vitro BMP-2 release study showed initial burst releases from the CLF hydrogels followed by sustained releases, regardless of the concentration of the BMP-2 over 4weeks. Cells in all groups were viable in the presence of the hydrogels regardless of BMP-2 doses, indicating non-cytotoxicity of hydrogels. Alkaline phosphate activity and mineralization of cells exhibited dose dependence on BMP-2 containing CLF hydrogels. Radiography, microcomputed tomography and histology confirmed that the BMP-2 containing CLF hydrogels prompted neo-osteogenesis and accelerated healing of the defects in a dose-dependent manner. Thus the CLF hydrogel is a promising delivery system of growth factors for bone regeneration.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RegenerationChitosanCompressive StrengthCross-Linking ReagentsDelayed-Action PreparationsDiffusionDioxanesDose-Response Relationship, DrugDrug CompoundingElastic ModulusFemoral FracturesFibrinogenHydrogelsLightBMP2 protein, humanBone Morphogenetic Protein 2ChitosanCross-Linking ReagentsDelayed-Action PreparationsdilactideDioxanesFibrinogenHydrogelsBMP-2ChitosanFibrinogenLactidePhoto-cross-linkable hydrogel

Identifiers

PMID25174669
PMCPMC4252590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.